Introduction
============

Natural products and functional-food ingredients gained interest due to their valuable biological effects including antioxidant, anticancer or antimicrobial. Currently, studies on natural products and medicinal plants are one of the most important subjects in pharmaceutical area ([@B51]). In these studies, many plants or plant-derived products are suggested as potential agents for designing new pharmaceuticals or food ingredients ([@B39]). However, there is still limited knowledge about chemical and biological profiles of many wild plant species used as folk remedies in traditional medicine.

Alzheimer's disease (AD) and Diabetes mellitus (DM) are considered major global health problems in the 21st century ([@B60]). Today, the prevalence of AD and DM is rising and is estimated to increase significantly over the next two decades. Consequently, many therapeutic strategies are developed for these health problems, and the key enzyme inhibitory theory is one of the most accepted approaches. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are the enzymes into synaptic cleft that terminates the cholinergic signal transfer, and which are considered targets for the treatment of AD. α-amylase and α-glucosidase are main enzymes involved in the catabolism of carbohydrates and they are of vital importance for decreasing post-prandial blood glucose level. Tyrosinase is a key enzyme in melanin biosynthesis and thus the inhibition of this enzyme is associated with the prevention of skin disorders (SD) ([@B45]). Several synthetic and natural inhibitors (galantamine and tacrine for AD; acarbose and voglibose for DM; kojic acid for SD) were developed for the management of these diseases by drug industry. However, many researches have reported that synthetic inhibitors have unfavorable effects such as nausea and diarrhea ([@B35]; [@B4]; [@B6]). Due to these adverse effects, there is an increasing search for inhibitors derived from natural products (non-toxic and effective) against key enzymes related with these diseases ([@B10]; [@B38]).

The genus *Potentilla* belongs to the Rosaceae family and is represented by about 500 species around the world ([@B54]). Also, the genus comprises about 53 species in Turkish Flora ([@B37]). *Potentilla* species have been used as traditional medicine for the treatment of various diseases. For example, *P. fulgens* Lodd. is used for the treatment of DM, cancer, stomach disorders, cough, and as wound healing ([@B52]; [@B42]; [@B19]; [@B43]). *P. mooniana* Wight. is used to treat gastric problems and mouth ulcers ([@B1]; [@B46]). Also, *P. fruticosa* L. has several medicinal properties including strengthening the stomach and the spleen, promoting metabolism, and it is widely used as a tea ([@B29]; [@B22]; [@B26]). Furthermore, *P. atrosanguinea* Lodd. has been used for wound healing, treating diarrhea, and influenza. Owing their potential uses in different purposes, several studies focused on the biological effects and chemical profile of the genus *Potentilla* ([@B55]; [@B56]; [@B57]). However, to the best of our knowledge, the biological and chemical fingerprints of *Potentilla reptans* Willd and *P. speciosa* L. have not yet been reported. Thus, the main purpose of present study is to evaluate biological (antioxidant capacity, enzyme inhibitory, and cytotoxic activities) and chemical (total bioactive components and individual phenolic compositions) fingerprints of *P. reptans* and *P. speciosa*. The obtained results will provide new insights on the members of this genus for potential phyto-pharmaceuticals and nutraceuticals development.

Materials and Methods {#s1}
=====================

Plant Materials
---------------

Taxonomic identification of the plant material was kindly confirmed by senior taxonomist Dr. Murad Aydın SANDA, from Department of Field Crops, Agriculture Faculty, Igdir University, Igdir, Turkey. Voucher specimens have been deposited at the Herbarium of the Department of Biology, Selcuk University, Konya, Turkey. Localities and collection periods of *Potentilla* species are as following:

*P. reptans*: Selcuk University, Alaaddin Keykubad Campus, Konya, Turkey, June 2015, (Voucher Number: GZ-1532).

*P. speciosa*: Nigde, Camardi, Mazmili Mountain, Turkey, July 2015 (Voucher Number: GZ-1560).

Preparation of the Extracts
---------------------------

Aerial parts plant materials were air-dried at room temperature. The dried plant materials were ground to a fine powder using a laboratory mill. The powdered plant samples (10 g) were extracted with 250 mL of solvent (ethyl acetate, methanol) using a Soxhlet apparatus for 6--8 h. Extracts were then filtered and concentrated under vacuum at 40°C by using a rotary evaporator. To obtain water extracts, powdered *P. reptans* and *P. speciosa* aerial parts (15 g) were boiled with 250 mL of distilled water for 30 min. The water extracts were then filtered and lyophilized \[--80°C, 48 h\]. Extracts were kept at 4°C (±1°C) in dark until further analysis. Abbreviation for these extracts are; Pr-EA (*Potentilla reptans* ethyl acetate), Pr-Met (*P. reptans* methanol), Pr-Wat (*P. reptans* water), Ps-EA (*Potentilla speciosa* ethyl acetate), Ps-Met (*P. speciosa* methanol), Ps-Wat (*P. speciosa* water).

Total Phenolics, Flavonoid, Saponins, Triterpenoids, and Phenolic Composition
-----------------------------------------------------------------------------

The total phenolic content was determined by employing the methods given in the literature ([@B48]) with some modification. Sample solution (1 mg/mL; 0.25 mL) was mixed with diluted Folin--Ciocalteu reagent (1 mL, 1:9, v/v) and shaken vigorously. After 3 min, Na~2~CO~3~ solution (0.75 mL, 1%) was added and the sample absorbance was read at 760 nm after a 2 h incubation at room temperature. The total phenolic content was expressed as milligrams of gallic acid equivalents (mg GAE/g extract) ([@B59]).

The total flavonoids content was determined using AlCl~3~ method ([@B66]). Briefly, sample solution (1 mg/mL; 1 mL) was mixed with the same volume of aluminum trichloride (2%) in methanol. Similarly, a blank was prepared by adding sample solution (1 mL) to methanol (1 mL) without AlCl~3~. The sample and blank absorbances were read at 415 nm after a 10 min incubation at room temperature. The absorbance of the blank was subtracted from that of the sample. Rutin was used as a reference standard and the total flavonoid content was expressed as milligrams of rutin equivalents (mg RE/g extract) ([@B31]).

The total saponins content of the extract was determined by the vanillin-sulfuric acid method ([@B2]). Sample solution (1 mg/mL; 0.25 mL) was mixed with vanillin (0.25 mL, 8%) and sulfuric acid (2 mL, 72%). The mixture was incubated for 10 min at 60°C. Then the mixture was cooled for another 15 min, followed by the sample absorbance measurement at 538 nm. The total saponin content was expressed as milligrams of quillaja equivalents (mg QAE/g extract).

The total triterpenoids content of the extracts was determined according to [@B68] method with some modifications. Briefly, sample solution (1 mg/mL; 500 μL) was mixed with the vanillin--glacial acetic acid (5%, w/v, 0.5 mL) and 1 mL of perchloric acid. The mixture was incubated at 60°C for 10 min, cooled in an ice water bath for 15 min and then 5 mL glacial acetic acid was added and mixed well. After 6 min, the absorbance was read at 538 nm. Oleanolic acid was used as a reference standard and the content of total triterpenoids was expressed as oleanolic acid equivalents (mg OAE/g extract) through a calibration curve with oleanolic acid.

HPLC-PDA analyses were performed on a Waters liquid chromatograph equipped with a model 600 solvent pump and a 2996 photodiode array detector, and Empower v.2 Software (Waters Spa, Milford, MA, United States) was used for acquisition of data. A C18 reversed-phase packing column (Prodigy ODS (3), 4.6 × 150 mm, 5 μm; Phemomenex, Torrance, CA, United States) was used for the separation and the column was thermostated at 30 ± 1°C using a Jetstream2 Plus column oven. The injection volume was 20 μL. The mobile phase was directly on-line degassed by using Biotech DEGASi, mod. Compact (LabService, Anzola dell'Emilia, Italy). Gradient elution was performed using the mobile phase water-acetonitrile (93:7, v/v, 3% acetic acid) ([@B65]). The UV/Vis acquisition wavelength was set in the range of 200--500 nm. The quantitative analyses were achieved at maximum wavelength for each compound.

Biological Activities Evaluation
--------------------------------

Antioxidant (DPPH and ABTS radical scavenging, reducing power (CUPRAC and FRAP), phosphomolybdenum, and metal chelating (ferrozine method)) and enzyme inhibitory activities \[cholinesterase (ChE) Elmann's method\], tyrosinase (dopachrome method), α-amylase (iodine/potassium iodide method), and α -glucosidase (chromogenic PNPG method)) were determined using the methods previously described by [@B66] and [@B11].

For the DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging assay: Sample solution (1 mg/mL; 1 mL) was added to 4 mL of a 0.004% methanol solution of DPPH. The sample absorbance was read at 517 nm after a 30 min incubation at room temperature in the dark. DPPH radical scavenging activity was expressed as millimoles of trolox equivalents (mg TE/g extract).

For ABTS (2,2′-azino-bis(3-ethylbenzothiazoline) 6-sulfonic acid) radical scavenging assay: Briefly, ABTS+ was produced directly by reacting 7 mM ABTS solution with 2.45 mM potassium persulfate and allowing the mixture to stand for 12--16 in the dark at room temperature. Prior to beginning the assay, ABTS solution was diluted with methanol to an absorbance of 0.700 ± 0.02 at 734 nm. Sample solution (1 mg/mL; 1 mL) was added to ABTS solution (2 mL) and mixed. The sample absorbance was read at 734 nm after a 30 min incubation at room temperature. The ABTS radical scavenging activity was expressed as millimoles of trolox equivalents (mmol TE/g extract) ([@B30]).

For CUPRAC (cupric ion reducing activity) activity assay: Sample solution (1 mg/mL; 0.5 mL) was added to premixed reaction mixture containing CuCl~2~ (1 mL, 10 mM), neocuproine (1 mL, 7.5 mM) and NH~4~Ac buffer (1 mL, 1 M, pH 7.0). Similarly, a blank was prepared by adding sample solution (0.5 mL) to premixed reaction mixture (3 mL) without CuCl~2~. Then, the sample and blank absorbances were read at 450 nm after a 30 min incubation at room temperature. The absorbance of the blank was subtracted from that of the sample. CUPRAC activity was expressed as milligrams of trolox equivalents (mg TE/g extract).

For FRAP (ferric reducing antioxidant power) activity assay: Sample solution (1 mg/mL; 0.1 mL) was added to premixed FRAP reagent (2 mL) containing acetate buffer (0.3 M, pH 3.6), 2,4,6-tris(2-pyridyl)-*S*-triazine (TPTZ) (10 mM) in 40 mM HCl and ferric chloride (20 mM) in a ratio of 10:1:1 (v/v/v). Then, the sample absorbance was read at 593 nm after a 30 min incubation at room temperature. FRAP activity was expressed as milligrams of trolox equivalents (mg TE/g extract).

For phosphomolybdenum method: Sample solution (1 mg/mL; 0.3 mL) was combined with 3 mL of reagent solution (0.6 M sulfuric acid, 28 mM sodium phosphate and 4 mM ammonium molybdate). The sample absorbance was read at 695 nm after a 90 min incubation at 95°C. The total antioxidant capacity was expressed as millimoles of trolox equivalents (mmol TE/g extract) ([@B33]).

For metal chelating activity assay: Briefly, sample solution (1 mg/mL; 2 mL) was added to FeCl~2~ solution (0.05 mL, 2 mM). The reaction was initiated by the addition of 5 mM ferrozine (0.2 mL). Similarly, a blank was prepared by adding sample solution (2 mL) to FeCl~2~ solution (0.05 mL, 2 mM) and water (0.2 mL) without ferrozine. Then, the sample and blank absorbances were read at 562 nm after 10 min incubation at room temperature. The absorbance of the blank was sub-tracted from that of the sample. The metal chelating activity was expressed as milligrams of EDTA (disodium edetate) equivalents (mg EDTAE/g extract).

For ChE inhibitory activity assay: Sample solution (1 mg/mL; 50 μL) was mixed with DTNB (5,5-dithio-bis(2-nitrobenzoic) acid, Sigma, St. Louis, MO, United States) (125 μL) and AChE \[acetylcholines-terase (Electric ell AChE, Type-VI-S, EC 3.1.1.7, Sigma)\], or BChE \[BChE (horse serum BChE, EC 3.1.1.8, Sigma)\] solution (25 μL) in Tris--HCl buffer (pH 8.0) in a 96-well microplate and incubated for 15 min at 25°C. The reaction was then initiated with the addition of acetylthiocholine iodide (ATCI, Sigma) or butyrylthiocholine chloride (BTCl, Sigma) (25 μL). Similarly, a blank was prepared by adding sample solution to all reaction reagents without enzyme (AChE or BChE) solution. The sample and blank absorbances were read at 405 nm after 10 min incubation at 25°C. The absorbance of the blank was subtracted from that of the sample and the cholinesterase inhibitory activity was expressed as galanthamine equivalents (mgGALAE/g extract) ([@B32]).

For Tyrosinase inhibitory activity assay: Sample solution (1 mg/mL; 25 μL) was mixed with tyrosinase solution (40 μL, Sigma) and phosphate buffer (100 μL, pH 6.8) in a 96-well microplate and incubated for 15 min at 25°C. The reaction was then initiated with the addition of L-DOPA (40 μL, Sigma). Similarly, a blank was prepared by adding sample solution to all reaction reagents without enzyme (tyrosinase) solution. The sample and blank absorbances were read at 492 nm after a 10 min incubation at 25°C. The absorbance of the blank was subtracted from that of the sample and the tyrosinase inhibitory activity was expressed as kojic acid equivalents (mgKAE/g extract) ([@B34]).

For α-amylase inhibitory activity assay: Sample solution (1 mg/mL; 25 μL) was mixed with α-amylase solution (ex-porcine pancreas, EC 3.2.1.1, Sigma) (50 μL) in phosphate buffer (pH 6.9 with 6 mM sodium chloride) in a 96-well microplate and incubated for 10 min at 37°C. After pre-incubation, the reaction was initiated with the addition of starch solution (50 μL, 0.05%). Similarly, a blank was prepared by adding sample solution to all reaction reagents without enzyme (α-amylase) solution. The reaction mixture was incubated 10 min at 37°C. The reaction was then stopped with the addition of HCl (25 μL, 1 M). This was followed by addition of the iodine-potassium iodide solution (100 μL). The sample and blank absorbances were read at 630 nm. The absorbance of the blank was subtracted from that of the sample and the α-amylase inhibitory activity was expressed as acarbose equivalents (mmol ACE/g extract) ([@B44]).

For α-glucosidase inhibitory activity assay: Sample solution (1 mg/mL; 50 μL) was mixed with glutathione (50 μL), α-glucosidase solution (from Saccharomyces cerevisiae, EC 3.2.1.20, Sigma) (50 μL) in phosphate buffer (pH 6.8) and PNPG (4-*N*-trophenyl-α-[D]{.smallcaps}-glucopyranoside, Sigma) (50 μL) in a 96-well microplate and incubated for 15 min at 37°C. Similarly, a blank was prepared by adding sample solution to all reaction reagents without enzyme (α-glucosidase) solution. The reaction was then stopped with the addition of sodium carbonate (50 μL, 0.2 M). The sample and blank absorbances were read at 400 nm. The absorbance of the blank was subtracted from that of the sample and the α-glucosidase inhibitory activity was expressed as acarbose equivalents (mmol ACE/g extract) ([@B27]).

All the assays were carried out in triplicate. The results are expressed as mean values and standard deviation (SD). The differences between the different extracts were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's honestly significant difference *post hoc* test with α = 0.05. This treatment was carried out using SPSS v. 14.0 program.

Cell Viability Assay
--------------------

Cell viability assay was performed for the extracts of the two *Potentilla* species ([@B13]). Human alveolar lung epithelial carcinoma (A549) and human breast adenocarcinoma (MCF-7) cells were cultured in 75 cm^2^ flasks containing RPMI 1640 medium supplemented, 10% FBS (fetal bovine serum) and antibiotics (100 mg/mL penicillin/streptomycin). Cells were grown in an atmosphere of 5% CO~2~ at 37°C (±1°C) with 95% humidity. The antiproliferative activities of *Potentilla* extracts were determined against A549 and MCF-7 cells using the MTT assay. Cells were seeded in 96-well plates (2 × 10^4^ cells per well) and maintained at 37°C (±1°C) with 5% CO~2~ atmosphere for 24 h before test extracts were added as DMSO solutions. Stock solutions were prepared by dissolving *Potentilla* extracts in DMSO (100 mg/mL) to reach a final DMSO concentration of 0.1%. Equal volume of DMSO (0.1%) was added into untreated wells. After incubation (for 24, 48, and 72 h), 50 μL of MTT solution (2 mg/mL in phosphate buffer saline) was added to each well. Afterwards, the plates were incubated for additional 4 h. DMSO was used for formazan solubilization and its UV absorbance was measured at 570 nm. Doxorubicin was used as the positive control. The percentage of cytotoxicity was calculated based on the comparison with untreated cells. All of the experiments were carried out in quadruplicate and the IC~50~ values were expressed as average ± SD. Statistical comparisons were estimated by one-way ANOVA followed by Duncan's *post hoc* test for multiple comparisons with control. Statistical analyses were performed using SPSS 16.0 software. A value of *p* \< 0.05 was considered to indicate statistical significance.

Results and Discussion
======================

Extraction Yield and Identification of Phenolic Compounds
---------------------------------------------------------

*Potentilla reptans* and *P. speciosa* were extracted using different solvents (ethyl acetate, methanol, and water) and extraction yields of samples are shown in **Table [1](#T1){ref-type="table"}**. The solvents used for extraction play a significant role on the extraction yield. The extraction yields increased in the following order: methanol \> water \> ethyl acetate. The highest extraction yield was for Pr-Met (20.61%).

###### 

Extraction yield and total bioactive components of different solvent extracts obtained from of *Potentilla reptans* and *P. speciosa^∗^.*

  Assays                                      *Potentilla reptans*   *Potentilla speciosa*                                                         
  ------------------------------------------- ---------------------- ----------------------- ----------------- ----------------- ----------------- -----------------
  Extraction yield (%)                        3.29                   20.61                   13.95             3.21              8.60              4.07
  Total phenolics (mg GAEs/g extract)^a^      42.13 ± 0.36c          111.68 ± 0.65b          135.73 ± 3.94a    24.98 ± 0.50c     102.58 ± 2.27b    138.45 ± 1.54a
  Total flavonoids (mg REs/g extract)^b^      25.10 ± 0.38c          37.95 ± 0.70a           30.56 ± 0.11b     9.34 ± 0.13c      29.83 ± 0.21a     16.30 ± 0.24b
  Total saponins (mg QEs/g extract)^c^        506.81 ± 33.84a        459.93 ± 30.68b         268.96 ± 18.09c   347.56 ± 71.26c   928.05 ± 56.65a   575.58 ± 22.41b
  Total triterpenoids (mg OAE/g extract)^d^   4.21 ± 0.12a           2.39 ± 0.07b            0.64 ± 0.01c      2.20 ± 0.13b      5.17 ± 0.03a      2.04 ± 0.07b
                                                                                                                                                   

a

GAEs, gallic acid equivalents;

b

REs, rutin equivalents;

c

QEs, quillaja equivalents;

d

OAEs, oleanolic acid equivalents.

∗

Values expressed are means ± SD; Data marked with different letters within the same row indicate statistically significant differences for each sample (

p

\< 0.05).

To understand the relationship between antioxidant capacity and phenolic components, the phenolic components of two *Potentilla* species were determined by using HPLC-PDA (**Figure [1](#F1){ref-type="fig"}**). As shown in **Table [2](#T2){ref-type="table"}**, two major compounds in all samples were identified as catechin (0.52--7.30 mg/g extract) and rutin (8.09--51.51 mg/g extract). Chemical structures of all identified phenolic compounds in *Potentilla* extracts are presented in **Figure [2](#F2){ref-type="fig"}**. These results are supported by the findings of [@B61] who reported that catechin, rutin, and ellagic acid were the most abundant compounds in *P. parvifolia* Fisch. ex Lehm. Furthermore, the aerial parts of *P. fruticosa* have been found to contain these phenolics (particularly elagic acid, catechins, and flavonols) ([@B14]). Catechin has been reported to be present in roots and rhizomes of *P. erecta* L., *P. anserina* L., *P. alba* L., and *P. viscosa* Donn ex Lehm. ([@B16]; [@B67]; [@B58]; [@B20]). Furthermore, catechin has been isolated from aerial parts of some *Potentilla* species such as *P. erecta*, *P. fruticosa*, and *P. fragarioides* L. ([@B15]; [@B20]; [@B8]; [@B29]). According to the study of [@B54], the dominant components in aerial parts of *Potentilla* species were flavonoids. A number of flavonoids (such as apigenin, kaempferol, quercetin, naringenin) have been identified from some *Potentilla* species (*P. viscosa*, *P. multifidi* L., *P. discolor* Bunge, and *P. erecta*) ([@B25]; [@B15]; [@B63]; [@B47]). Biological properties of rutin have been also reported including antibacterial, antitumor, anti-inflammatory ([@B7]), antiallergic ([@B69]), anticarcinogenic ([@B62]), and antioxidant ([@B64]). On the basis of these considerations, rutin and catechin could play an important role in the biological effects of the investigated *Potentilla* extracts. The other phenolic compounds were observed in minor amounts. Ferulic and cinnamic acids were not detected in any sample. Nonetheless, tannins and triterpenoids are also known as significant biologically active components of the genus *Potentilla* ([@B63]; [@B24]; [@B54]).

![**HPLC-PDA analyses of the three different extracts (ethyl acetate, methanol, and water) for the two *Potentilla* species; chromatographic profiles are reported at 280 nm**.](fphar-08-00290-g001){#F1}

###### 

Phenolic compounds of *P. reptans* and *P. speciosa* (mg/g extract)*^∗^.*

  No   Compounds                 Retention Time (min)   Wavelength (nm)   *Potentilla reptans*   *Potentilla speciosa*                                                  
  ---- ------------------------- ---------------------- ----------------- ---------------------- ----------------------- --------------- -------------- --------------- ---------------
  1    Gallic acid               4.40 ± 0.06            271               0.10 ± 0.03b           0.02 ± 0.01c            0.80 ± 0.13a    0.10 ± 0.04b   0.15 ± 0.04b    1.49 ± 0.45a
  2    Catechin                  11.9 ± 0.27            278               4.89 ± 0.98a           nd                      0.52 ± 0.17b    2.28 ± 0.85c   5.53 ± 1.02b    7.30 ± 1.28a
  3    Chlorogenic acid          12.7 ± 0.23            324               0.03 ± 0.01b           nd                      0.16 ± 0.07a    nd             nd              0.21 ± 0.07
  4    *p*-OH benzoic acid       13.2 ± 0.20            256               nd                     0.02 ± 0.01a            0.03 ± 0.01a    0.34 ± 0.09a   0.27 ± 0.07b    0.33 ± 0.08a
  5    Vanillic acid             15.7 ± 0.19            260               0.16 ± 0.05b           0.67 ± 0.06a            0.09 ± 0.01c    0.19 ± 0.07a   0.17 ± 0.05a    0.20 ± 0.09a
  6    Epicatechin               16.4 ± 0.23            278               0.07 ± 0.02b           0.70 ± 0.11a            nd              0.15 ± 0.03b   nd              0.34 ± 0.10a
  7    Syringic acid             16.7 ± 0.17            274               nd                     0.06 ± 0.01b            1.90 ± 0.23a    nd             nd              nd
  8    3-OH benzoic acid         16.9 ± 0.21            295               nd                     nd                      0.47 ± 0.18     nd             nd              0.16 ± 0.09
  9    3-OH-4-MeO benzaldehyde   20.4 ± 0.18            275               nd                     5.63 ± 1.07             nd              0.03 ± 0.01b   0.83 ± 0.15a    nd
  10   *p*-coumaric acid         22.0 ± 0.19            309               0.06 ± 0.01a           0.01 ± 0.005b           nd              0.15 ± 0.07c   0.19 ± 0.06b    0.29 ± 0.11a
  11   Rutin                     24.0 ± 0.14            256               8.09 ± 1.01c           21.80 ± 3.58b           51.51 ± 5.19a   3.37 ± 1.01c   9.21 ± 0.99b    11.01 ± 1.21a
  12   Sinapic acid              24.5 ± 0.16            324               nd                     0.09 ± 0.02a            0.07 ± 0.02a    0.06 ± 0.01a   0.08 ± 0.01a    0.05 ± 0.01a
  13   *t*-Ferulic acid          26.1 ± 0.14            315               nd                     nd                      nd              nd             nd              nd
  14   Naringin                  28.4 ± 0.13            285               0.13 ± 0.04c           0.30 ± 0.08b            0.46 ± 0.10a    0.14 ± 0.06c   1.39 ± 0.47a    1.03 ± 0.33b
  15   2.3-diMeO benzoic acid    28.7 ± 0.14            299               0.46 ± 0.11c           0.99 ± 0.14b            1.97 ± 0.24a    0.07 ± 0.02b   1.66 ± 0.55a    nd
  16   Benzoic acid              29.4 ± 0.14            275               nd                     0.65 ± 0.13             nd              0.03 ± 0.01c   0.76 ± 0.11b    1.24 ± 0.41a
  17   *o*-Coumaric acid         30.2 ± 0.16            276               0.04 ± 0.01a           0.06 ± 0.02a            nd              nd             0.020 ± 0.008   nd
  18   Quercetin                 39.9 ± 0.24            367               nd                     0.30 ± 0.09a            0.17 ± 0.08b    0.31 ± 0.12c   3.40 ± 0.98a    1.03 ± 0.34b
  19   *t*-Cinnamic acid         42.7 ± 0.23            276               nd                     nd                      nd              nd             nd              nd
  20   Naringenin                46.0 ± 0.04            290               0.28 ± 0.10b           0.64 ± 0.12a            0.11 ± 0.03c    0.04 ± 0.01a   0.01 ± 0.004b   nd
                                                                                                                                                                        

nd: not determined;

∗

Values expressed are means ± SD; Data marked with different letters within the same row indicate statistically significant differences for each sample (

p

\< 0.05).

![**Phenolic compounds identified in *Potentilla* species**.](fphar-08-00290-g002){#F2}

Determination of the Total Phenolics, Flavonoids, Saponins, and Triterpenoids Content
-------------------------------------------------------------------------------------

Besides identified compounds, many other compounds might be responsible for the biological effects of investigated species. In this study, the values of total phenolics, flavonoids, saponins, and triterpenoids content are shown in **Table [1](#T1){ref-type="table"}**. Total phenolics content of *Potentilla* extracts varied from 24.98 to 138.45 mg GAE/g. Ps-Wat (138.45 mg GAE/g extract) had the highest phenolics content, whereas the Ps-EA (24.98 mg GAE/g extract) had the lowest content. Contrary to our results, [@B49] found that ethyl acetate extract of *P. recta* and *P. astracanica* Jacq. contained higher total phenolics content compared to butanol and water extracts. [@B56] reported that the total phenolics content was 116.0 mg GAE/g in water extracts of *P. reptans* which is lower than for Pr-Wat (135.73 mg GAE/g), in the present study. The total phenolics content of different solvent extracts of *P. atrosanguinea* was reported by [@B17] who found that the hydroalcoholic extract showed higher phenolic content (429.8 mg GAE/g dry weight of extract). Several authors also reported the total phenolics contents of *Potentilla* species indicating them as valuable sources of bioactive compounds ([@B55]; [@B61]; [@B49]).

The total flavonoids content of *Potentilla* species ranged from 9.34 to 37.95 mg RE/g extract. The highest values were obtained from Pr-Met, Pr-Wat, and Ps-Met with 37.95, 30.56, and 29.83 mg RE/g extract, respectively. The lowest total content value was obtained from Ps-EA with 9.34 mg RE/g extract. Total flavonoids content of some *Potentilla* species was also reported by [@B55], [@B49], and [@B56]. As for total saponins content, Ps-Met (928.05 mg QE/g extract) contained the highest total saponins content, followed by Pr-EA (506.81 mg QE/g) and Pr-Met (459.93 mg QE/g). According to the results, water extracts contained lower total saponins content than other extracts. These findings agree with the previous results obtained by [@B57]. Nonetheless, Ps-Met (5.17 mg OAE/g) had the highest total triterpenoids content. The lowest amount of total triterpenoids content was obtained from Pr-Wat.

Free Radical Scavenging Activity and Total Antioxidant Capacity
---------------------------------------------------------------

The free radical scavenging activity of *P. reptans* and *P. speciosa* was evaluated using the DPPH and ABTS radical scavenging assays. As shown in **Table [3](#T3){ref-type="table"}**, the values of DPPH radical scavenging activity for *P. speciosa* and *P. reptans* ranged from 46.51 to 334.66 mg TE/g and from 0.61 to 4.55 mmol TE/g in ABTS radical scavenging activity, respectively. In the DPPH assay, Pr-Met and Ps-Met displayed more potent radical scavenging activity than other extracts. Additionally, in the ABTS assay, Pr-Wat (4.55 mmol TE/g extract) and Ps-Wat (4.17 mmol TE/g extract) had the highest radical scavenging activity among all samples. [@B56] reported that the aerial parts and rhizome extracts of *P. reptans* showed DPPH radical scavenging activity with IC~50~ value of 12.11 and 2.57 μg/ml. In another study, [@B17] found that H~2~O/MeOH crude extract of *P. atrosanguinea* exhibited the highest DPPH radical scavenging activity (90.04 %) followed by EtOAc (88.10%) and *n*-BuOH (82.37%) at 200 μg/ml. Besides, [@B26] reported that the ABTS values of *P. fruticosa* varied from 303 to 1309 μmol TE/g. In addition, researchers have reported that different *Potentilla* species have important radical scavenging activities ([@B9]; [@B41]; [@B61]).

###### 

Antioxidant properties of different solvent extracts obtained from of *P. reptans* and *P. speciosa^∗^.*

  Assays                                      *Potentilla reptans*   *Potentilla speciosa*                                                     
  ------------------------------------------- ---------------------- ----------------------- ---------------- --------------- ---------------- ----------------
  DPPH scavenging (mg TEs/g extract)^a^       119.54 ± 4.97c         331.98 ± 1.26a          292.10 ± 6.57b   46.51 ± 6.82c   334.66 ± 0.70a   200.54 ± 9.88b
  ABTS scavenging (mmol TEs/g extract)^a^     2.06 ± 0.12c           4.39 ± 0.06b            4.55 ± 0.19a     0.61 ± 0.07c    3.62 ± 0.10b     4.17 ± 0.19a
  CUPRAC (mg TEs/g extract)^a^                131.03 ± 2.18b         263.39 ± 3.11a          261.41 ± 1.88a   91.85 ± 1.93b   264.62 ± 3.25a   269.18 ± 3.37a
  FRAP (mg TEs/g extract)^a^                  81.59 ± 1.76c          204.10 ± 0.39b          219.97 ± 2.06a   56.97 ± 0.82c   191.53 ± 3.47b   214.49 ± 1.84a
  Phosphomolybdenum (mmol TEs/g extract)^a^   1.64 ± 0.06c           2.62 ± 0.02b            2.73 ± 0.15a     1.12 ± 0.03c    2.34 ± 0.02b     3.03 ± 0.08a
  Metal chelating (mg EDTAEs/g extract)^b^    6.87 ± 0.33c           20.04 ± 0.51b           32.86 ± 0.07a    3.45 ± 0.76c    9.09 ± 1.33b     26.94 ± 1.70a
                                                                                                                                               

a

TEs, trolox equivalents;

b

EDTAEs, disodium edetate equivalents;

∗

Values expressed are means ± SD; Data marked with different letters within the same row indicate statistically significant differences for each sample (

p

\< 0.05).

Total antioxidant capacities of *Potentilla* extracts were determined using phosphomolybdenum assay and the results were depicted in **Table [3](#T3){ref-type="table"}**. Ps-Wat, Pr-Wat, and Pr-Met exhibited important total antioxidant capacities with the values of 3.03, 2.73, and 2.62 mmol TE/g extract, respectively. According also to the DPPH and ABTS results, the ethyl acetate extracts of both investigated *Potentilla* species demonstrated lowest antioxidant activity in phosphomolybdenum assay.

Reducing Power and Metal Chelating Activity
-------------------------------------------

FRAP and CUPRAC assays were used to determine reducing power activity of *Potentilla* species. The water extracts exhibited more pronounced activity as compared to other extracts in both CUPRAC and FRAP assays (**Table [3](#T3){ref-type="table"}**). The lowest reducing power activity was observed for ethyl acetate extracts. The reducing power activity of the methanol extract of *P. speciosa* root (FRAP: 133.35 and CUPRAC: 189.24 mg TE/g) was significantly lower than results obtained for aerial parts of *P. speciosa* (FRAP: 191.53 and CUPRAC: 264.62 mg TE/g) ([@B65]). [@B26] reported that the FRAP values of *P. fruticosa* collected from eight locations ranged from 112.24 to 436.58 μmol TE/g. In addition, [@B17] evaluated CUPRAC activities of different fractions of root extract of *P. atrosanguinea* in which the H~2~O/MeOH extract exhibited the highest reducing activity followed by *n*-BuOH, EtOAc, and H~2~O fraction at 200 μg/ml.

In the metal chelating assay, Pr-Wat (32.86 mg EDTAE/g) and Ps-Wat (26.94 mg EDTAE/g) were the most active, whereas the Pr-EA (6.87 mg EDTAE/g) and Ps-EA (3.45 mg EDTAE/g) were the least active. The ethyl acetate extracts of the studied *Potentilla* extracts showed the lowest metal chelating activities and these results are supported as well by the previous findings of [@B57]. In our previous study, we reported that metal chelating activity for the methanol extract of *P. speciosa* root was 4.32 mg EDTAE/g ([@B65]), and this value is lower than the one obtained herein for aerial part of *P. speciosa* (9.09 mg EDTAE/g).

Enzyme Inhibitory Activity
--------------------------

The inhibitory activities of tested extracts against cholinesterases (AChE and BChE), α-amylase, α-glucosidase, and tyrosinase were tested and the results are presented in **Table [4](#T4){ref-type="table"}**. The inhibitory activities against all enzymes ranged according to the extraction solvents. Generally, the water extract demonstrated a lower activity against all enzymes. The ethyl acetate and methanol extracts showed prominent inhibitory effects against AChE. Moreover, the highest BChE inhibitory activities were obtained from the Pr-EA and Ps-Wat with 6.15 and 2.87 mg GALAE/g. However, Ps-Met was inactive against BChE. There are several reports in literature indicating that terpenoid and phenolic compounds have promising cholinesterase inhibitory activities ([@B36]; [@B50]; [@B5]). Accordingly, terpenoid and phenolic rich *Potentilla* species could be considered as promising AChE and BChE inhibitors.

###### 

Enzyme inhibitory activities of different solvent extracts obtained from of *P. reptans* and *P. speciosa^∗^.*

  Assays                                             *Potentilla reptans*   *Potentilla speciosa*                                                     
  -------------------------------------------------- ---------------------- ----------------------- --------------- ---------------- ---------------- ---------------
  AChE Inhibition (mg GALAE/g extract)^a^            3.99 ± 0.08a           3.56 ± 0.22b            1.30 ± 0.22c    3.55 ± 0.22b     3.76 ± 0.06a     0.71 ± 0.06c
  BChE Inhibition (mg GALAE/g extract)^a^            6.15 ± 0.37a           0.09 ± 0.01c            0.52 ± 0.01b    1.43 ± 1.17c     nd               2.87 ± 0.27a
  α-Amylase inhibition (mmol ACE/g extract)^b^       1.99 ± 0.07a           1.29 ± 0.18b            0.36 ± 0.01c    1.46 ± 0.25b     2.41 ± 0.44a     0.38 ± 0.01c
  α-Glucosidase inhibition (mmol ACE/g extract)^b^   4.94 ± 1.70c           54.19 ± 0.57a           40.99 ± 2.62b   2.80 ± 0.93c     54.57 ± 0.14a    38.59 ± 6.20b
  Tyrosinase inhibition (mg KAE/g extract)           108.56 ± 6.13b         123.36 ± 4.63a          31.48 ± 4.19c   106.54 ± 9.63b   144.39 ± 1.49a   35.60 ± 4.12c
                                                                                                                                                      

a

GALAEs, galantamine equivalents;

b

ACEs, acarbose equivalents;

c

KAEs, kojic acid equivalents nd: not determined.

∗

Values expressed are means ± SD. Data marked with different letters within the same row indicate statistically significant differences for each sample (

p

\< 0.05).

The anti-diabetic activity of *Potentilla* species was investigated by testing their inhibition abilities on α-amylase and α-glucosidase (**Table [4](#T4){ref-type="table"}**). In α-glucosidase inhibitory activity, Pr-Met and Ps-Met showed the highest inhibitory activities with the values of 54.19 and 54.57 mmol ACE/g, respectively. Similarly, to our results, [@B21] reported that methanol extracts from *P. fulgens* have strong inhibitory activity against α-glucosidase, and ethyl acetate fraction exhibited potent α-glucosidase inhibitory activity. In addition, these authors found that isolated terpenoids from *P. fulgens* demonstrated significant α-glucosidase inhibitory activity. Similarly, several triterpenoids and phenolics exhibited antidiabetic activities ([@B18]; [@B23]; [@B28]; [@B12]; [@B3]). Thus, the presence of these components in *Potentilla* species could be correlated with the observed antidiabetic activity.

The tyrosinase inhibitory activity of the studied *Potentilla* species ranged from 31.48 to 144.39 mg KAE/g. As shown in **Table [4](#T4){ref-type="table"}**, Ps-Met (144.39 mg KAE/g) and Pr-Met (123.36 mg KAE/g) displayed remarkable tyrosinase inhibitory activities. Additionally, the lowest tyrosinase inhibitory activities were observed in Pr-Wat (31.48 mg KAE/g) and Ps-Wat (35.60 mg KAE/g).

Cytotoxicity
------------

Although some of the best anticancer drugs are from natural origin or derived, they present also negative effects on human health. Therefore, investigation of medicinal plants for discovery of potent anticancer compounds having fewer side effects is warranted. In this work, the cytotoxic activity of extracts from *P. reptans* and *P. speciosa* was determined against two human cancer cell lines (A549 and MCF-7). IC~50~ values were expressed as mean of quadruplicates ± SD (**Table [5](#T5){ref-type="table"}**). The highest cytotoxicity was observed for water extract of *P. reptans* (IC~50~ \< 130 μg/ml). Compared to the positive control, doxorubicin (IC~50~ = 9.6 and 2.5 μg/ml against A549 and MCF-7 cells in 48 h, respectively), *P. reptans* showed high antiproliferative activity against MCF-7 cells. *P. speciosa* exhibited weak to moderate activity against both of A549 and MCF-7 cell lines. The cytotoxicity rate of A549 and MCF-7 cells was found to be time dependent (**Table [5](#T5){ref-type="table"}**). In general, crude extracts with IC~50~ values less than 1000 μg/ml could be considered to be active. Several classes of natural compounds found in *Potentilla* species could be responsible for their antiproliferative activity. Previous studies revealed that triterpenoids, tannins and phenolic compounds isolated from *Potentilla* species exhibited cytotoxic activities against some human cancer cell lines ([@B22]; [@B54]; [@B9]; [@B40]). For example two flavonoids (such as chrysin) from *P. evestita* Th.Wolf showed prominent cytotoxic and antitumor promoting properties ([@B40]). Also, DNA topoisomerase I and II inhibitory activity has been observed for phenolic compounds isolated from *P. argentea* L. ([@B53]). In comparison to previous studies, *P. reptans* exhibited moderate to high cytotoxicity. According to our literature review, this is the first report concerning the antiproliferative activity of extracts obtained from *P. reptans and P. speciosa*. However, further phytochemical and pharmacological studies are needed for identification of responsible compounds and evaluation of the molecular mechanism of their anticancer action.

###### 

Cytotoxicity of different solvent extracts obtained from *P. reptans* and *P. speciosa* (IC50 μg/ml)*^∗^*.

  Cell line   Time (h)   *Potentilla reptans*   *Potentilla speciosa*   Doxorubicin                                               
  ----------- ---------- ---------------------- ----------------------- ------------- -------------- -------------- ------------- ---------------
  MCF-7       24         156 ± 6.2a             90 ± 2.2b               130 ± 2.5c    482 ± 14*d*    660 ± 35*e*    710 ± 46*e*   7.8 ± 0.4*f*
              48         85 ± 2.8a              55 ± 1.4b               90 ± 3.2a     287 ± 15c      390 ± 18*d*    425 ± 16*e*   2.5 ± 0.1*f*
              72         65 ± 1.4a              42 ± 1.2b               70 ± 2.2a     248 ± 6.4c     312 ± 7.5*d*   350 ± 11*e*   2.1 ± 0.1*f*
  A549        24         490 ± 9.0a             443 ± 8.4b              89 ± 1.6c     101 ± 2.5*d*   990 ± 38*e*    705 ± 22*f*   22.4 ± 1.1*g*
              48         298 ± 8.1a             305 ± 10a               65.5 ± 3.3b   73.6 ± 4.9b    662 ± 19c      430 ± 11*d*   9.6 ± 0.6*e*
              72         163 ± 3.5a             180 ± 4.4b              52 ± 1.2c     60 ± 1.4*d*    424 ± 8.8*e*   297 ± 10*f*   8.2 ± 0.7*g*
                                                                                                                                  

∗

Values expressed are means ± SD. Data marked with different letters indicate significant difference (

p

\< 0.05).

Conclusion
==========

To sum up all, in the present work, different biological effects for two *Potentilla* species were observed as well as their chemical profiles. From our results, it was apparent that the biological activities and chemical profiles were dependent on extraction solvents and their polarity. Rutin and catechin were the major phenolic components identified in these extracts. Generally, the methanol and water extracts showed higher antioxidant activities as compared to ethyl acetate extracts. Furthermore, investigated *Potentilla* species revealed good inhibitory properties on tested enzymes linked to major health problems (AD and DM), and MCF-7 cells. From the present results, these two *Potentilla* species could be considered as promising sources of natural-biologically active agents for pharmaceutical and food industries. However, further experimental studies such as *in vivo* animal models and toxicological assays are recommended for the studied *Potentilla* species.
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